JP2019514977A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514977A5
JP2019514977A5 JP2018558279A JP2018558279A JP2019514977A5 JP 2019514977 A5 JP2019514977 A5 JP 2019514977A5 JP 2018558279 A JP2018558279 A JP 2018558279A JP 2018558279 A JP2018558279 A JP 2018558279A JP 2019514977 A5 JP2019514977 A5 JP 2019514977A5
Authority
JP
Japan
Prior art keywords
valerian
dosage form
pharmaceutical dosage
pharmaceutical
polymer matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018558279A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514977A (ja
JP7576905B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/031046 external-priority patent/WO2017192843A1/en
Publication of JP2019514977A publication Critical patent/JP2019514977A/ja
Publication of JP2019514977A5 publication Critical patent/JP2019514977A5/ja
Priority to JP2022089010A priority Critical patent/JP7577090B2/ja
Application granted granted Critical
Publication of JP7576905B2 publication Critical patent/JP7576905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018558279A 2016-05-06 2017-05-04 バレリアン組成物及び関連方法 Active JP7576905B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022089010A JP7577090B2 (ja) 2016-05-06 2022-05-31 バレリアン組成物及び関連方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662332728P 2016-05-06 2016-05-06
US62/332,728 2016-05-06
PCT/US2017/031046 WO2017192843A1 (en) 2016-05-06 2017-05-04 Valerian composition and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022089010A Division JP7577090B2 (ja) 2016-05-06 2022-05-31 バレリアン組成物及び関連方法

Publications (3)

Publication Number Publication Date
JP2019514977A JP2019514977A (ja) 2019-06-06
JP2019514977A5 true JP2019514977A5 (cg-RX-API-DMAC7.html) 2022-01-06
JP7576905B2 JP7576905B2 (ja) 2024-11-01

Family

ID=60203773

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018558279A Active JP7576905B2 (ja) 2016-05-06 2017-05-04 バレリアン組成物及び関連方法
JP2022089010A Active JP7577090B2 (ja) 2016-05-06 2022-05-31 バレリアン組成物及び関連方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022089010A Active JP7577090B2 (ja) 2016-05-06 2022-05-31 バレリアン組成物及び関連方法

Country Status (10)

Country Link
US (4) US10342873B2 (cg-RX-API-DMAC7.html)
EP (1) EP3452020A4 (cg-RX-API-DMAC7.html)
JP (2) JP7576905B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190008265A (cg-RX-API-DMAC7.html)
CN (2) CN117482062A (cg-RX-API-DMAC7.html)
AU (1) AU2017260019A1 (cg-RX-API-DMAC7.html)
CA (1) CA3023305C (cg-RX-API-DMAC7.html)
MX (1) MX2018013569A (cg-RX-API-DMAC7.html)
RU (1) RU2018142019A (cg-RX-API-DMAC7.html)
WO (1) WO2017192843A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023510223A (ja) * 2020-01-17 2023-03-13 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 徐放性メラトニンペレットを含む剤形
IT202200013576A1 (it) * 2022-06-27 2023-12-27 S I I T S R L Servizio Int Imballaggi Termosaldanti Compressa multistrato a rilascio differenziato di melatonina e principi attivi

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2699075A1 (fr) * 1992-12-11 1994-06-17 Rech Sarl Ab Préparation médicinale à libération programmable dans le temps notamment à base de plantes.
FR2713636B1 (fr) 1993-12-07 1996-01-05 Adir Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent.
FR2727315A1 (fr) 1994-11-30 1996-05-31 Cooperative Agricole Laitiere Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires
US5840332A (en) 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
PT1027043E (pt) 1996-12-10 2005-02-28 Bristol Myers Squibb Co Benzodioxole benzofurano di-hidrobenzofurano e benzodioxano como agentes melatonergicos
US6383526B1 (en) 1999-07-21 2002-05-07 Ancile Pharmaceuticals, Inc. Process for the extraction of valerian root
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
US20050129783A1 (en) 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
JP4532903B2 (ja) * 2001-12-20 2010-08-25 アルペックス ファーマ ソシエテ アノニム 微粒子組成物
JP4951162B2 (ja) 2004-04-06 2012-06-13 太陽化学株式会社 睡眠改善用組成物
EP2258349B1 (en) * 2004-05-11 2014-07-16 Egalet Ltd. Swellable dosage form comprising gellan gum
JP5254618B2 (ja) 2004-10-11 2013-08-07 ナサリーズ・ピーピーエム・リミテッド 経鼻投与用組成物
CA2612090C (en) 2005-06-22 2014-06-10 Takeda Pharmaceutical Company Limited Tablet containing hardly soluble active ingredient
AU2006338839A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
CN1850212A (zh) * 2006-02-28 2006-10-25 潮州市强基制药厂 一种缬草油液体硬胶囊及其制备方法
EP2066333B1 (de) 2006-09-27 2013-12-25 Finzelberg GmbH & Co. KG Baldrian-extraktzubereitung
US20080248106A1 (en) 2007-04-05 2008-10-09 Marvin Heuer Melatonin-based composition for improved sleep
US20090197974A1 (en) * 2008-02-05 2009-08-06 Khaleeq Ahmed Natural dietary supplement tablet
US8809395B2 (en) 2009-01-23 2014-08-19 Valericon Gmbh Methods for making valerenic acid derivatives and their use
US20110064720A1 (en) 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
CN102370833B (zh) * 2010-08-17 2014-03-26 北京亚东生物制药有限公司 一种解表祛暑的泡腾剂及其制备方法和用途
CN102058630B (zh) * 2010-12-16 2014-03-19 苏州大学 一种镇静安神的缬草制剂及其制备方法
CN102247443A (zh) * 2010-12-23 2011-11-23 祝凤仪 治疗神经衰弱中药外洗粉、泡腾片的配方及其制备方法
MX2013008314A (es) 2011-01-17 2013-09-26 Takeda Pharmaceutical Tableta dispersable en forma oral.
WO2012103411A2 (en) * 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
CN102114060B (zh) * 2011-02-22 2012-12-12 都晓伟 黑水缬草提取物及其制备方法和应用
JP2013053144A (ja) * 2011-08-09 2013-03-21 Daiichi Sankyo Healthcare Co Ltd 鎮静剤組成物
WO2013061161A2 (en) * 2011-10-28 2013-05-02 Green Bcn Consulting Services Sl New combination therapies for treating neurological disorders
RU2631602C2 (ru) 2012-01-26 2017-09-25 Ванда Фармасьютиклз Инк. Лечение нарушений циркадного ритма
WO2013113027A2 (en) 2012-01-26 2013-08-01 Wikicell Designs, Inc Enclosing materials in natural transport systems
WO2014083438A2 (en) 2012-11-09 2014-06-05 Abattis Bioceuticals Corp Nitric oxide increasing nutritional supplements and methods
US20140271890A1 (en) 2013-03-14 2014-09-18 Thaer Ahmad Controlled-release pharmaceutical composition
CA2881992C (en) 2013-04-23 2016-11-22 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
PL231923B1 (pl) 2013-10-28 2019-04-30 Proteon Pharmaceuticals Spolka Akcyjna Sposób enkapsulacji materiału zawierającego bakteriofagi, otrzymywana nim mikrokapsułka oraz jej zastosowania
RU2535020C1 (ru) 2014-01-23 2014-12-10 Карпов Алексей Николаевич Фармацевтическая композиция седативного и спазмолитического действия
EP3632416A1 (en) * 2014-02-06 2020-04-08 Lan Bo Chen Composition and method for aiding sleep
HUE042861T2 (hu) * 2014-05-05 2019-07-29 Sanofi Aventis Deutschland Gyorsan oldódó granulátum
PT2974733T (pt) 2014-07-14 2016-10-24 Dr Willmar Schwabe Gmbh & Co Kg Combinação de extracto de raiz de valeriana e óleo de alfazema para tratamento de distúrbios de sono

Similar Documents

Publication Publication Date Title
FI3287124T3 (fi) Ketamiinin oraalinen annosmuoto
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
JP2016540021A5 (cg-RX-API-DMAC7.html)
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
MX2015011896A (es) Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia.
JP2015523407A5 (cg-RX-API-DMAC7.html)
JP2012193216A5 (cg-RX-API-DMAC7.html)
AR084865A1 (es) Preparacion de desintegracion rapida, comprimido dispersable por via oral
RU2015143515A (ru) Твердые таблетки и капсулы модифицированного высвобождения бензонатата
BR112012019374A2 (pt) composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo
JP2013523694A5 (cg-RX-API-DMAC7.html)
JP2024507991A (ja) 激越を処置するための方法及び組成物
NZ605469A (en) Nalbuphine-based formulations and uses thereof
JP2013541583A5 (cg-RX-API-DMAC7.html)
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
MX2019015733A (es) Formulacion de melatonina oralmente disoluble con agente acidificante que produce melatonina soluble en saliva.
JP2019529570A5 (cg-RX-API-DMAC7.html)
CN110062628A (zh) 一种瑞卡帕布口服缓控释药物组合物及其用途
JP2009507048A5 (cg-RX-API-DMAC7.html)
JP2019514977A5 (cg-RX-API-DMAC7.html)
JP5403935B2 (ja) 経口用の慢性疼痛予防または治療剤
JP2022116251A5 (cg-RX-API-DMAC7.html)
JP2014513130A5 (cg-RX-API-DMAC7.html)
CA2648538A1 (en) Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles
JP2016538288A5 (cg-RX-API-DMAC7.html)